OPIANT PHARMACEUTICALS, INC.·4

Jul 15, 4:04 PM ET

Gorman Brian 4

4 · OPIANT PHARMACEUTICALS, INC. · Filed Jul 15, 2022

Insider Transaction Report

Form 4
Period: 2022-07-14
Transactions
  • Sale

    Common Stock

    2022-07-14$11.16/sh691$7,71233,747 total
Footnotes (2)
  • [F1]These shares were sold to cover tax withholding obligations in connection with the vesting of performance stock units.
  • [F2]This transaction was executed in multiple trades at prices ranging from $10.83 to $11.47. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Documents

1 file
  • 4
    wf-form4_165791544287123.xmlPrimary

    FORM 4